Kiniksa Pharmaceuticals
(NASDAQ:KNSA)
Kiniksa Pharmaceuticals, Ltd. - Class A Common Stock is expected to split Monday, August 15, 2022 with a ratio of 1:5
Kiniksa Pharmaceuticals, Ltd. - Class A Common Stock recently split on Friday, August 12, 2022 with a ratio of 1:3
$12.41
0.25[2.06%]
At close: Aug 12
$12.41
After Hours: 4:01PM EDT
Day High/Low11.99 - 12.64
52 Week High/Low7.36 - 13.75
Open / Close12.22 / 12.41
Float / Outstanding24.2M / 69.5M
Vol / Avg.404.9K / 338.1K
Mkt Cap862.1M
P/E-
50d Avg. Price10.42
Div / Yield-
Payout Ratio-
EPS-0.29
Total Float24.2M

Kiniksa Pharmaceuticals (NASDAQ:KNSA), Quotes and News Summary

Kiniksa Pharmaceuticals (NASDAQ: KNSA)

Day High/Low11.99 - 12.64
52 Week High/Low7.36 - 13.75
Open / Close12.22 / 12.41
Float / Outstanding24.2M / 69.5M
Vol / Avg.404.9K / 338.1K
Mkt Cap862.1M
P/E-
50d Avg. Price10.42
Div / Yield-
Payout Ratio-
EPS-0.29
Total Float24.2M
Sector: Health Care.Industry: Biotechnology
Kiniksa Pharmaceuticals Ltd is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. Its clinical-stage product candidates include Rilonacept, for the treatment of recurrent pericarditis, a debilitating inflammatory cardiovascular disease; Mavrilimumab, a monoclonal antibody for the treatment of giant cell arteritis; Vixarelimab; and KPL-404.

Earnings

see more
FY 2023Est.ActualSurprise
EPS
(EXPECTED)2023-12-20
REV
FY 2023Est.ActualSurprise
EPS
(EXPECTED)2023-11-09
REV

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Kiniksa Pharmaceuticals Questions & Answers

Q
How do I buy Kiniksa Pharmaceuticals (KNSA) stock?
A

You can purchase shares of Kiniksa Pharmaceuticals (NASDAQ: KNSA) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are Kiniksa Pharmaceuticals's (KNSA) competitors?
Q
What is the target price for Kiniksa Pharmaceuticals (KNSA) stock?
A

The latest price target for Kiniksa Pharmaceuticals (NASDAQ: KNSA) was reported by Cantor Fitzgerald on Friday, August 12, 2022. The analyst firm set a price target for 4.00 expecting KNSA to fall to within 12 months (a possible -67.77% downside). 50 analyst firms have reported ratings in the last year.

Q
Current Stock Price for Kiniksa Pharmaceuticals (KNSA)?
A

The stock price for Kiniksa Pharmaceuticals (NASDAQ: KNSA) is $12.41 last updated August 12, 2022, 8:00 PM UTC.

Q
Does Kiniksa Pharmaceuticals (KNSA) pay a dividend?
A

The next Kiniksa Pharmaceuticals (KNSA) dividend date is projected to be Thursday, September 1, 2022.

Q
When is Kiniksa Pharmaceuticals (NASDAQ:KNSA) reporting earnings?
A

Kiniksa Pharmaceuticals’s FY earnings are confirmed for Wednesday, December 20, 2023.

Q
Is Kiniksa Pharmaceuticals (KNSA) going to split?
A

There is no upcoming split for Kiniksa Pharmaceuticals.

Q
What sector and industry does Kiniksa Pharmaceuticals (KNSA) operate in?
A

Kiniksa Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.